Objectives: The use of ultrasound imaging for cancer diagnosis and screening can be enhanced with the use of molecularly targeted microbubbles. Nonlinear imaging strategies such as pulse inversion (PI) and "contrast pulse sequences" (CPS) can be used to differentiate microbubble signal, but often fail to suppress highly echogenic tissue interfaces. This failure results in false-positive detection and potential misdiagnosis. In this study, a novel acoustic radiation force (ARF)-based approach was developed for superior microbubble signal detection. The feasibility of this technique, termed ARF decorrelation-weighted PI (ADW-PI), was demonstrated in vivo using a subcutaneous mouse tumor model. Materials and Methods: Tumors were implanted in the hindlimb of C57BL/6 mice by subcutaneous injection of MC38 cells. Lipid-shelled microbubbles were conjugated to anti-VEGFR2 antibody and administered via bolus injection. An image sequence using ARF pulses to generate microbubble motion was combined with PI imaging on a Verasonics Vantage programmable scanner. ADW-PI images were generated by combining PI images with interframe signal decorrelation data. For comparison, CPS images of the same mouse tumor were acquired using a Siemens Sequoia clinical scanner. Results: Microbubble-bound regions in the tumor interior exhibited significantly higher signal decorrelation than static tissue (n = 9, P < 0.001). The application of ARF significantly increased microbubble signal decorrelation (n = 9, P < 0.01). Using these decorrelation measurements, ADW-PI imaging demonstrated significantly improved microbubble contrast-to-tissue ratio when compared with corresponding CPS or PI images (n = 9, P < 0.001). Contrast-to-tissue ratio improved with ADW-PI by approximately 3 dB compared with PI images and 2 dB compared with CPS images. Conclusions: Acoustic radiation force can be used to generate adherent microbubble signal decorrelation without microbubble bursting. When combined with PI, measurements of the resulting microbubble signal decorrelation can be used to reconstruct images that exhibit superior suppression of highly echogenic tissue interfaces when compared with PI or CPS alone.
M
icrobubbles are lipid-shelled perfluorocarbon gas bubbles that are used as ultrasound contrast agents for medical imaging due to their high echogenicity and biocompatibility. [1] [2] [3] When insonified at diagnostic ultrasound frequencies, microbubbles exhibit a substantial nonlinear response, which may be relatively easy to distinguish from linear reflections (ie, fundamental, nonharmonic echoes) produced by most tissues. 4 Because of their high echogenicity and generation of harmonic signals, nontargeted microbubbles are currently approved for use in medical settings to visualize left ventricular opacification. 5 Other studies have employed nontargeted microbubbles in patients with hepatocellular carcinomas to enhance the signal of color or power Doppler and increase diagnostic confidence. [6] [7] [8] [9] [10] However, the ability of microbubbles to perfuse into the microvasculature has led to growing interest in the molecular targeting of microbubbles in tumor settings, where circulating microbubbles can bind specifically to cancer disease markers present on endothelial tissue. 11, 12 The ability to identify tumorigenic tissue based on molecular targeting rather than the presence of anatomical features can greatly improve the sensitivity and specificity of diagnostic ultrasound imaging. There is a growing body of interest in using targeted microbubbles for enhanced screening and treatment monitoring of cancer, particularly in the prostate. 12, 13 Phase 0 clinical trials have already been completed using commercial BR55 microbubbles [14] [15] [16] in human prostate cancer patients (Clinical Trial ID: NCT01253213); phase 1 to 2 studies are now in progress (Clinical Trial ID: NCT02142608).
Common nonlinear microbubble imaging techniques such as "contrast pulse sequences" (CPS) 17 or pulse inversion (PI) 18 are often used to visualize microbubbles through the extraction of harmonic signals. However, these methods are susceptible to misclassifying harmonic signals produced by highly echogenic tissue surfaces such as bone or vascular walls. 19 Therefore, 1 significant challenge in imaging ultrasound contrast agents is isolating the harmonic signal generated by tissue-bound microbubbles while suppressing harmonic signal from all other tissues. 20 The limitations of traditional nonlinear imaging techniques are directly related to the physical properties of static tissue because highly echogenic tissue boundaries tend to generate harmonic signal. While the harmonic-to-fundamental ratio within tissue may be lower than that of microbubbles, sufficiently echogenic tissue interfaces will generate reflections in both the fundamental and harmonic frequencies strong enough to be clearly visible in most ultrasound imaging systems. 19 Moreover, harmonic signal amplitudes increase nonlinearly with transmit power, which compounds this effect as transmit pressure increases. 21 Since conventional contrast pulse sequence techniques exhibit insufficient cancelation of harmonics from highly echogenic tissue interfaces, new strategies are needed. Several groups have recently proposed new strategies involving time domain filters rather than the frequency domain, as a way to better isolate microbubble signal based on the rapid disappearance of bound microbubbles in response to destructive or near-destructive acoustic pressures. Couture and colleagues developed a form of ultrafast imaging to isolate the signal from bound microbubbles in vitro based on the rapid changes in microbubble signal intensity immediately before and after the administration of a disruption pulse. 22 Our laboratory has previously demonstrated that signal from adherent microbubbles in large vessel environments can be isolated based on the distinct statistical signature exhibited by microbubbles in response to shear forces from flow, without the administration of a destruction pulse. 20, [23] [24] [25] [26] Acoustic radiation force (ARF) has been employed in several past studies to encourage the specific binding of microbubbles to the vascular wall, both in vivo and in vitro. [27] [28] [29] [30] [31] In this study, ARF is not applied to facilitate microbubble targeting, but instead to induce motion of the adherent microbubbles. It is hypothesized that the applied ARF induces small microbubble displacements, which give rise to a unique decorrelation signal.
In this study, we sought to use nondestructive imaging pressures to induce small movements of microbubbles, and separate the movement of microbubbles from static tissue based on their unique interframe signal decorrelation properties. Real-time signal decorrelation data were used to visualize bound microbubbles within the microvasculature, where individual vessels and the vessel wall cannot be resolved at typical diagnostic ultrasound frequencies. Decorrelation data were combined with traditional nonlinear imaging and harmonic filtering techniques to achieve improved contrast-to-tissue ratio (CTR) and signal specificity. Results demonstrated that combining ARF with interframe signal decorrelation of microbubbles can attenuate strong signal from echogenic tissue reflectors to an extent that has not been achieved by previous nonlinear imaging methods.
MATERIALS AND METHODS

Microbubble Preparation
Biotinylated gas-filled microbubbles were produced by a standard sonication protocol 32 from decafluorobutane gas (F2 Chemicals; Lancashire, United Kingdom) by dispersing gas in a lipid micellar mixture of distearoyl phosphatidylcholine (Avanti Polar Lipids; Alabaster, AL), polyethylene glycol stearate (Stepan Kessco, Elwood, IL), and biotin-PEG3400-distearoylphosphatidylethanolamine (PEG-DSPE; Shearwater Polymers, Huntsville, AL) in normal saline to create microbubbles coated with a lipid monolayer shell. After preparation, microbubbles were sealed in vials under decafluorobutane headspace atmosphere and stored refrigerated. Immediately before antibody coupling, microbubbles were centrifuged for 10 minutes (140 g) in degassed phosphate-buffered saline to eliminate the excess of unincorporated lipid from the solution and counted using a Coulter Multisizer 3 (Beckman Coulter, Brea, CA).
Biotinylated microbubbles were conjugated to biotinylated antimouse VEGFR2 antibody (clone Avas 12a1; eBioscience, San Diego, CA)
14,33-35 using streptavidin (Anaspec Inc, Fremont, CA) as a linking molecule. 36 Streptavidin was added to the biotinylated microbubble solution at a concentration of 3 μg/10 million microbubbles and incubated for 15 minutes at room temperature. During incubation, the microbubbles were gently agitated every 2 minutes to ensure mixing. This microbubble solution was washed twice with phosphate-buffered saline to remove excess streptavidin and counted again. Next, the biotinylated anti-VEGFR2 antibody was added to the microbubbles at 1.5 μg per 10 million microbubbles and incubated for 10 minutes. Two more washing steps were performed to remove the excess antibody. Microbubble count and size distribution was acquired before each experiment.
In Vivo Mouse Model
After an institutionally approved animal care and use committee protocol, female C57BL/6 mice received subcutaneous hindlimb injections of murine colon adenocarcinoma cells (MC38, generously provided by Dr J. Schlom, National Institutes of Health, Bethesda, MD). The tumors were allowed to grow for approximately 10 days. During imaging, the mice were anesthetized with 2% isoflurane gas (Henry Schein, Dublin, OH) and secured on a heated motion stage (TM150; Indus Instruments, Webster, TX) in the prone position. The tumorcarrying leg was secured, and the skin over the tumor was depilated. An imaging plane within the tumor was located using a Verasonics programmable scanner, and the transducer was secured in place. The tumor was imaged before microbubble injection. A bolus injection of 2 Â 10 7 microbubbles was administered retro-orbitally and allowed to circulate and bind for 15 minutes before imaging. [37] [38] [39] [40] The microbubble-bound tumors were then imaged again using a Verasonics programmable scanner and a Siemens Sequoia commercial scanner (Fig. 1 ).
Tumor Imaging and Measurement of ARF-Based Signal Decorrelation
Tumors were imaged using a 128-element L12-5 38mm linear array transducer (Philips Healthcare, Andover, MA). The imaging sequence was programmed on a Verasonics programmable ultrasound scanner (Vantage 256; Verasonics, Redmond, WA) and involved a combination of PI and synthetic aperture virtual source element imaging. 41, 42 The 64 central transmit and receive elements were designated as the synthetic aperture, with 22 virtual source elements distributed laterally with foci located 35 mm behind the transducer face. Each virtual source element transmitted a positive and negative waveform, and the resulting 44 receive signals (1 positive and 1 negative receive for each source element) were summed to create 1 complete PI image. This PI image acquisition was followed by a B-mode image, in which only the positive transmit/receive signals from each virtual source were performed and summed. Pulse inversion imaging was transmitted at a frequency of 5.5 MHz, and a bandpass filter was applied to the receive signal, centered at the first harmonic (11 MHz). B-mode transmit and receive was performed at a center frequency of 11 MHz, within the passband of the applied filter. In-phase/quadrature (IQ) data were used for all receive signals to preserve variations in both signal amplitude and phase.
Control sequences in which no ARF was applied consisted of 1 PI image and 1 B-mode image, followed by a delay of approximately 3 milliseconds, then a second PI and B-mode image acquisition. The transducer position was held stationary throughout all B-mode and PI image sequences in a given tumor. In the ARF sequences, ten 15-cycle, 4.4-MHz ARF waveforms were transmitted at a pulse repetition frequency of 11.4 kHz for 875 μs during the 3 milliseconds delay (Fig. 1 ). For both control and ARF sequences, the complete sequence of transmit events was repeated at a frame rate of approximately 15 Hz for 5 seconds. Acoustic radiation force transmissions had a measured MI of 0.12 and peak negative pressure of approximately 0.25 MPa. For comparison to a commercially available standard of nonlinear imaging, 43 CPS images of the microbubble-bound tumor were taken using a Siemens Sequoia clinical scanner with a 15L8-5 transducer, at a center frequency of 7 MHz and frame rate of 12 Hz. These images were taken immediately after the ARF, and no-ARF trial data had been collected. FIGURE 1. Sequence of imaging events used to create 1 frame of an ADW-PI image. An initial 5.5-MHz PI transmit signal was followed immediately by an 11-MHz B-mode transmit signal. A train of 10 ARF waveforms (4.5 MHz) was then transmitted at a pulse repetition frequency of 11.4 kHz for 875 μs, followed by post-ARF PI and B-mode transmissions identical to the first transmits. This entire sequence was repeated at a frame rate of 15 Hz for 5 seconds. In control experiments, the ARF waveforms were omitted. Figure 1 can be viewed online in color at www.investigativeradiology.com.
After data acquisition, pairs of B-mode and PI images corresponding to events directly before and after the application of ARF were used to assess localized decorrelation. As described in the next section, measurements of signal decorrelation at each image pixel were then used to weight the intensity of the original PI images. Decorrelationweighted PI images were generated for both preinjection and postinjection data sets within a given tumor. The purpose of the preinjection image data was to serve as a control to determine that the imaging technique accentuated the tumor interior only when microbubbles were present. Contrast between preinjection and postinjection signal intensity was measured based on regions of interest (ROIs) within the tumor interior. Microbubble CTR was calculated from ROIs within decorrelationweighted PI images selected both inside the tumor, where microbubbles were visible, and outside of the tumor, where static tissue was visible. Corresponding Sequoia CPS images were matched to the same tumors and analyzed for calculation of microbubble CTR. Since acquisition of CPS images required the use of a different scanner, the exact same imaging plane could not be compared between CPS and PI imaging modes. To obtain CPS images that were comparable to those taken using the Verasonics scanner, freehand CPS data were acquired while sweeping the scanner imaging plane across the tumor volume. Then, a representative image that best matched the size and orientation of the original tumor image was selected for analysis.
ARF Decorrelation-Weighted PI Filtering
Acoustic radiation force decorrelation-weighted PI (ADW-PI) images created from mouse tumor images in a multistep process as illustrated by Figure 2 . Incoming data from PI image sequences ( Fig. 2A) were in the form of IQ sample data. For each sample in an image, a 3 Â 3 window surrounding the sample of interest was selected for both pre-ARF and post-ARF images. The correlation coefficient between pre-ARF and post-ARF windows was calculated using the "corrCoef " function in MATLAB, and signal decorrelation was calculated as the complement of signal correlation. This calculation, when performed for all samples in the image, resulted in a decorrelation image.
Measured signal decorrelation between PI frames was assumed to arise from 2 additive sources: motion and electronic noise. To isolate decorrelation arising from motion only, several processing steps were performed to estimate, and account for, the decorrelation due to electronic noise. To estimate decorrelation from electronic noise, it was FIGURE 2. Flowchart showing the basic processing steps used to generate the ARF decorrelation-weighted image of a mouse tumor with adherent targeted microbubbles. Signal decorrelation was measured between pre-ARF and post-ARF PI frames (A). Decorrelation due to electronic noise (B) was calculated and subtracted from the raw decorrelation image, resulting in a "motion-based decorrelation" image (C). A Gaussian-shaped remapping filter (D) centered at the decorrelation of microbubbles was used to eliminate low-decorrelation signal from tissue and high-decorrelation signal from random electronic noise. The resulting decorrelation-weighted remapping filter (E) was used to weight the intensity of one of the original PI frames to produce the final ARF decorrelation-weighted PI image (F). Figure 2 can be viewed online in color at www.investigativeradiology.com.
assumed that signal decorrelation arising from electronic noise could be approximated by the following equation 44 :
where ρ r1r2 is the signal-to-noise (SNR) based correlation coefficient between two signals. A measurement of noise intensity through depth was acquired by collecting 50 frames of receive data without any transmission signal while applying the same time gain compensation settings as used in all imaging experiments. In the absence of an ultrasound transmit, only electronic noise was received by the system. Each A-line of each frame of electronic noise was averaged to obtain an approximation of noise intensity though depth (Fig. 2B) . To estimate the combined signal and noise intensity for each ultrasound image, a root-mean-square calculation was performed for every sample in the PI image using a 3 Â 3 window of values from which to calculate rootmean-square. An estimate of the signal and noise could then be computed for each pixel in each image, and these values were applied to Equation 1 to obtain an estimate of the signal decorrelation component due to electronic noise alone. The noise-based decorrelation image was then subtracted from the original decorrelation image to generate an estimate of signal decorrelation arising from motion (Fig. 2C) . Motion-induced decorrelation images were remapped using a Gaussian-shaped remapping filter centered at the expected decorrelation range exhibited by microbubbles. The Gaussian mapping function parameters for standard deviation and mean were applied uniformly for all data sets and set by optimizing specificity to microbubble signal using all frames of ADW-PI image data collected from each mouse in the study. For each mouse in the study, the ADW-PI image was reconstructed using 15 decorrelation images that were spatially median filtered and then compounded. The resulting compounded decorrelation image was multiplied by the original PI image to form the final ADW-PI image.
When displaying ADW-PI images, a parameter α was used to set the intensity of decorrelation values lower than those encompassed by the Gaussian-shaped remapping filter. These low-decorrelation signals were assumed to be static tissue. High values of α allowed for more tissue signal to be displayed in ADW-PI images, whereas lower values of α caused tissue signal suppression.
Signal Decorrelation Analysis
Filtered signal decorrelation images for ARF and no-ARF trials were generated, and rectangular ROIs corresponding to microbubblebound tumor tissue or normal static tissue were selected (Fig. 3) . For each tumor, microbubble ROIs were approximately 5 Â 5 mm in size, whereas tissue ROIs were approximately 3 Â 3 mm in size. These ROIs, as well as transducer position, were held stationary between control and ARF sequences for each tumor. For tissue ROIs, the most apparent static tissue signal visible in the PI image was chosen for analysis via the ROI placement. For microbubble ROIs, ROIs that did not overlap with visible static tissue were chosen. Average signal decorrelation between each image pair was calculated within the ROIs, and decorrelation measurements were averaged across approximately 30 frames (ie, approximately 2 seconds) for a single mouse trial. Signal decorrelation was calculated in this way for both control and ARF sequences, and averaged across all mice (n = 9).
Statistical Methods
Signal decorrelation was compared between tissue and microbubble ROIs using a 2-tailed t test for both ARF and no-ARF trials. The difference between signal decorrelation measured in ARF and no-ARF trials was assessed using a 1-tailed t test. Microbubble CTR was compared between B-mode, PI, CPS, and ADW-PI images using a 2-tailed t test. Contrast between preinjection and postinjection tumor images was measured using a 1-tailed t test.
RESULTS
Decorrelation of Microbubbles in Response to ARF
Across 9 mice, the mean decorrelation within microbubble ROIs for PI image pairs was 0.028 when ARF was not applied and 0.043 when ARF was applied. The increased signal decorrelation within microbubble-bound regions allowed for significant differentiation between ARF-insonated microbubble signal and static tissue signal (P < 0.001). Furthermore, a 1-sided t test performed on the difference between the microbubble signal decorrelations of ARF and no-ARF trials showed that the measured microbubble signal decorrelation for ARF trials was significantly higher than that of no-ARF trials (P < 0.01). Our control measurements of tissue signal decorrelation in both ARF and no-ARF trials also showed that ARF does not increase decorrelation uniformly throughout the entire image. No statistically significant difference in tissue signal decorrelation was found between ARF and no-ARF conditions (Fig. 4) .
ADW-PI Improvements in CTR
Employing ADW-PI resulted in significantly improved CTR when compared with B-mode, PI, or CPS imaging alone. Acoustic radiation force-based decorrelation weighting allowed for effective suppression of echogenic tissue interfaces from nearby bone structures visible in B-mode, PI, and CPS images of the same tumor (Fig. 5) . The CTR of ADW-PI was increased by almost 2 dB when compared with corresponding CPS images, and at least 3 dB when compared with corresponding B-mode and PI images (Fig. 6) . The decorrelation-based filter was adjusted to different levels of the parameter α to allow for complete cancelation of static tissue signal, or limited visualization of surrounding tissue structures (Fig. 7) . Measurements of contrast between postinjection and preinjection intratumor ROIs showed an average signal enhancement of 17.6 dB (P < 0.05) after injection of microbubbles.
DISCUSSION
Current microbubble imaging techniques such as PI and CPS use amplitude or phase modulation to cancel tissue signal. These methods are effective in preserving nonlinear reflections from microbubbles, but they can fail to completely eliminate nonlinear reflections from strong tissue interfaces. The false-positive signals arising from these interfaces can make accurate diagnosis more difficult and require more time and skill on the part of clinicians to properly interpret contrast-enhanced ultrasound images. Studies in the past that employ ultrasound molecular imaging for cancer diagnosis have addressed this problem through manual segmentation of the tumor interior. 40, 43, 45 However, manual segmentation requires time and prior knowledge of the general location, orientation, and environment of a potential tumor, which can vary based on the specific patient and the disease being diagnosed. All of these factors make it more difficult for contrast-enhanced targeted molecular imaging to be readily adopted in a diagnostic clinical setting. Previous studies have shown how improvements in microbubble CTR are necessary to significantly improve diagnostic accuracy in the clinic. 46, 47 The results presented in this study showed that interframe signal decorrelation can serve as an additional form of microbubble signal differentiation. Microbubble signal within the tumor exhibited significantly higher interframe signal decorrelation than static tissue, with and without the application of ARF (P < 0.005). It was also found that the application of ARF significantly increased the signal decorrelation of microbubbles (P < 0.01), without causing significant changes in tissue signal decorrelation. Finally, this study showed that the proposed ADW-PI image processing technique improved microbubble CTR when compared with PI alone or CPS. Comparison of postmicrobubble injection ADW-PI signal to premicrobubble injection control further demonstrated that ADW-PI isolated the microbubble signal rather than the tumor tissue (17.6 dB average contrast improvement; P < 0.05).
There are several sources of microbubble movement that were possible contributors to the microbubble signal decorrelation observed in this study. First, secondary radiation forces may have resulted in lateral and out-of-beam motion of microbubbles as they deformed or detached from the vessel wall in response to applied ARF. Kokhuis and colleagues 48 found that secondary radiation forces can manifest as attraction between individual targeted microbubbles in vitro and cause rapid deformation of microbubbles into a prolate shape. These deformations in the microbubble shell could have manifested as axial motion, which results in a detectable phase shift and resulting signal decorrelation. It has also been found that as ARF insonation pressure increases, secondary radiation force can overcome molecular binding forces, and allow bound microbubbles to dislodge or cluster. [48] [49] [50] Loughran and colleagues 49 determined that the peak negative pressure necessary for secondary radiation forces to overcome the molecular binding forces of adherent microbubbles was approximately 150 kPa. In the imaging sequence employed in this study, PI, B-mode, and ARF transmissions had peak negative pressures of 286, 115, and 255 kPa, respectively, without accounting for attenuation. As a result, it is possible that some portion of microbubbles detached from the vessel wall even in the absence of ARF pulses. The addition of ARF pulses in the imaging sequence likely resulted in a higher percentage of bound microbubbles that dislodged over time, and the resulting increase in out-of-beam motion may account for the higher signal decorrelation observed in ARF versus no-ARF trials (Fig. 4) .
The dynamics of blood flow in the tumor microvasculature may be another source of bound microbubble movement and signal decorrelation. Previous studies performed by Wang and colleagues 20 have shown that shear forces from flow are a primary cause of microbubble signal decorrelation in large blood vessels, as continuous microbubble aggregation and dislodgement creates out-of-beam motion. This motion leads to significant increases in the adherent microbubble normalized FIGURE 4. Plot of PI decorrelation data. Both no-ARF and ARF trials show significant difference between tissue and microbubble signal decorrelation (**P < 0.005; ***P < 0.0001; n = 9). The application of ARF was shown to significantly increase microbubble signal decorrelation from no-ARF conditions (*P < 0.01). single spectrum area values, which has been shown to be monotonic with signal decorrelation. 20 Shear forces are more difficult to characterize in the microvasculature of a tumor, where blood flow is nonNewtonian with lower velocity. 51 However, the combination of shear and collision forces from red blood cells in the tumor are likely to induce out-of-beam detachment of targeted microbubbles, similar to what has been observed in large vessels. Owen and colleagues 51 performed in vitro studies of targeted microbubbles in small vessels (using cellulose tubes 200 μm in diameter), which showed how targeted microbubbles may be perturbed and dislodged, or fail to bind with endothelial cells in the first place, due to collision with circulating erythrocytes. This out-of-beam motion resulting from tumor-bound microbubble collision and dislodgement could possibly lead to an increase in local signal decorrelation, as dislodged microbubbles circulate and contribute to free microbubble signal.
Based on previous studies that have shown high specificity of VEGFR2-targeted microbubbles to the tumor endothelium, it is assumed that the microbubble signal detected during imaging experiments were derived from specific binding. 33, 34, 52, 53 Previous studies employing mouse tumor models have shown no significant difference between nonspecific uptake in tumor tissue versus normal tissue. 37, 54 Within our own laboratory, previous studies of targeted microbubbles in vitro have provided optical verification that nonspecific binding from applied ARF is minimal. 55 The concentration of targeted biomarkers in a tumor is correlated with the amount of adherent microbubbles present in the image, 38 and signal enhancement is monotonic with microbubble concentration. 56 It is important to observe that all measurements of signal decorrelation were acquired using IQ data, which contains both real and complex components of the received signal. When complex echo data were ignored and only the absolute signal intensity was used to calculate interframe signal decorrelation, no statistically significant difference was found between ARF-insonated microbubbles and no-ARF microbubbles. These results indicate that phase information, acquired from the complex component of echo data, is important in revealing an ARF-based enhancement in microbubble signal decorrelation. Since changes in signal phase are correlated with axial motion of microbubbles, assessed through the "slow-time," frame-to-frame dimension, it is possible that the enhancement of decorrelation in ARF-insonated trials is due to axial movement of adherent microbubbles.
The importance of using complex echo data to detect enhanced signal decorrelation from ARF agrees with previous literature showing that singular value filtering methods have superior performance when complex echo data are used. 23 Previous studies by the authors of this article determined that in the case of singular value filtering, axial movement of acoustic targets can lead to signal basis functions with highly overlapping frequencies. This frequency overlap leads to periodicity in real echo data while complex echo data were not affected. 23 This FIGURE 7 . Visualization of the image filtering method employed, at various levels of the α parameter. A, PI data for a microbubble-bound tumor before any filtering was applied. B-D, ADW-PI images after a simple Gaussian filter was applied to the signal decorrelation, centered at the measured decorrelation of microbubble signal. The value of α determined the level at which the signal components exhibiting low-decorrelation, corresponding to static tissue, were displayed. When α was set to zero, the microbubbles were isolated from all other anatomical features. For imaging, the same ROIs used for decorrelation calculations were used to measure CTR. These values were averaged across all frames in each mouse (n = 9). For CPS images, 1 frame from each mouse tumor was used to measure CTR (n = 9). Measured ADW-PI CTR was found to be significantly higher than all other imaging modalities (*P < 0.001).
discrepancy between real and complex echo data could relate to the decorrelation-based filtering method proposed in this article, as singular values from complex data are monotonic with signal decorrelation. Fully processed images from a Sequoia scanner in CPS contrast mode were used to compare the CTR between CPS and ADW-PI. CPS data were displayed on a 0 to 50 dB dynamic range, and calculations of CPS CTR assumed linear gamma mapping in grayscale. However, it is likely that nonlinear steps were used to form the final CPS image. While the assumption of image linearity may have led to minor inaccuracy in CTR measurements, calculations of CTR were still viable for an approximate comparison between 2 contrast imaging modes.
In this study, it was demonstrated that long duration ARF pulses can be used to generate a signal decorrelation signature that is highly specific to microbubbles. As a result, a new imaging approach that combines the decorrelation information with PI, called ADW-PI, was developed and the specificity of this approach was compared with PI alone and CPS. It was determined that the application of ARF can significantly increase microbubble interframe signal decorrelation in vivo. It was also determined that in conditions both with and without ARF, microbubble signal decorrelation is significantly higher than that of static tissue. The improved robustness from ADW-PI or similar decorrelation-based methods with regards to signal specificity may serve to improve clinical adoption of targeted microbubbles by reducing false-positive detection.
